These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 26403197)
21. Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle. Badgujar DC; Anil A; Green AE; Surve MV; Madhavan S; Beckett A; Prior IA; Godsora BK; Patil SB; More PK; Sarkar SG; Mitchell A; Banerjee R; Phale PS; Mitchell TJ; Neill DR; Bhaumik P; Banerjee A PLoS Pathog; 2020 Nov; 16(11):e1009016. PubMed ID: 33216805 [TBL] [Abstract][Full Text] [Related]
22. [Research progress in pneumolysin]. Rui W; Nie K; Fang R Wei Sheng Wu Xue Bao; 2017 Mar; 57(3):333-40. PubMed ID: 29756432 [TBL] [Abstract][Full Text] [Related]
23. Crystallization and preliminary X-ray diffraction analysis of a functional form of pneumolysin, a virulence factor from Streptococcus pneumoniae. Kelly SJ; Jedrzejas MJ Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1452-5. PubMed ID: 11053849 [TBL] [Abstract][Full Text] [Related]
24. The solution structure and oligomerization behavior of two bacterial toxins: pneumolysin and perfringolysin O. Solovyova AS; Nöllmann M; Mitchell TJ; Byron O Biophys J; 2004 Jul; 87(1):540-52. PubMed ID: 15240487 [TBL] [Abstract][Full Text] [Related]
25. Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins. Baba H; Kawamura I; Kohda C; Nomura T; Ito Y; Kimoto T; Watanabe I; Ichiyama S; Mitsuyama M Biochem Biophys Res Commun; 2001 Feb; 281(1):37-44. PubMed ID: 11178957 [TBL] [Abstract][Full Text] [Related]
26. Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting pneumolysin and sortase A. Song M; Teng Z; Li M; Niu X; Wang J; Deng X J Cell Mol Med; 2017 Oct; 21(10):2586-2598. PubMed ID: 28402019 [TBL] [Abstract][Full Text] [Related]
27. Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins. Aziz UBA; Saoud A; Bermudez M; Mieth M; Atef A; Rudolf T; Arkona C; Trenkner T; Böttcher C; Ludwig K; Hoelzemer A; Hocke AC; Wolber G; Rademann J Nat Commun; 2024 Apr; 15(1):3537. PubMed ID: 38670939 [TBL] [Abstract][Full Text] [Related]
28. Apigenin protects mice from pneumococcal pneumonia by inhibiting the cytolytic activity of pneumolysin. Song M; Li L; Li M; Cha Y; Deng X; Wang J Fitoterapia; 2016 Dec; 115():31-36. PubMed ID: 27693741 [TBL] [Abstract][Full Text] [Related]
29. The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent. Harvey RM; Hughes CE; Paton AW; Trappetti C; Tweten RK; Paton JC PLoS One; 2014; 9(8):e103625. PubMed ID: 25105894 [TBL] [Abstract][Full Text] [Related]
30. Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin release. Bryant JC; Dabbs RC; Oswalt KL; Brown LR; Rosch JW; Seo KS; Donaldson JR; McDaniel LS; Thornton JA BMC Microbiol; 2016 Nov; 16(1):271. PubMed ID: 27829373 [TBL] [Abstract][Full Text] [Related]
31. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608 [TBL] [Abstract][Full Text] [Related]
32. Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines. Lu J; Sun T; Hou H; Xu M; Gu T; Dong Y; Wang D; Chen P; Wu C; Liang C; Sun S; Jiang C; Kong W; Wu Y Immunol Invest; 2014; 43(7):717-26. PubMed ID: 25020076 [TBL] [Abstract][Full Text] [Related]
33. Structural and functional analogy between pneumolysin and proaerolysin. Sowdhamini R; Mitchell TJ; Andrew PW; Morgan PJ Protein Eng; 1997 Mar; 10(3):207-15. PubMed ID: 9153085 [TBL] [Abstract][Full Text] [Related]
35. Pneumolysin: a double-edged sword during the host-pathogen interaction. Marriott HM; Mitchell TJ; Dockrell DH Curr Mol Med; 2008 Sep; 8(6):497-509. PubMed ID: 18781957 [TBL] [Abstract][Full Text] [Related]
36. Juglone alleviates pneumolysin-induced human alveolar epithelial cell injury via inhibiting the hemolytic activity of pneumolysin. Song M; Lu G; Li M; Deng X; Wang J Antonie Van Leeuwenhoek; 2017 Aug; 110(8):1069-1075. PubMed ID: 28451868 [TBL] [Abstract][Full Text] [Related]
37. Oligomerisation of pneumolysin on cholesterol crystals: similarities to the behaviour of polyene antibiotics. Sonnen AF; Rowe AJ; Andrew PW; Gilbert RJ Toxicon; 2008 Jun; 51(8):1554-9. PubMed ID: 18501941 [TBL] [Abstract][Full Text] [Related]
39. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media. Keller LE; Bradshaw JL; Pipkins H; McDaniel LS Front Cell Infect Microbiol; 2016; 6():55. PubMed ID: 27242973 [TBL] [Abstract][Full Text] [Related]
40. Protective role of Cav-1 in pneumolysin-induced endothelial barrier dysfunction. Batori RK; Chen F; Bordan Z; Haigh S; Su Y; Verin AD; Barman SA; Stepp DW; Chakraborty T; Lucas R; Fulton DJR Front Immunol; 2022; 13():945656. PubMed ID: 35967431 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]